Fluidigm to Report Q3 2016 Financial Results and Host Conference Call
Oct 24, 2016 20:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2016 -- Fluidigm Corporation (NASDAQ:FLDM) today announced it will report third quarter 2016 financial results on Thursday, November 3, 2016, after the financial markets close. ...
Fluidigm to Report Q3 2016 Financial Results and Host Conference Call
Oct 24, 2016 20:06 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2016 -- Fluidigm Corporation (NASDAQ:FLDM) today announced it will report third quarter 2016 financial results on Thursday, November 3, 2016, after the financial markets close. ...
Connecture to Release 2016 Third Quarter Financial Results on November 7, 2016
Oct 24, 2016 20:05 pm UTC| Business
BROOKFIELD, Wis., Oct. 24, 2016 -- Connecture, Inc. (Nasdaq:CNXR), a provider of web-based information systems used to create health insurance marketplaces, will release its 2016 third quarter financial results on...
Diversicare to Announce Third Quarter 2016 Financial Results on Thursday, November 3, 2016
Oct 24, 2016 20:05 pm UTC| Business
BRENTWOOD, Tenn., Oct. 24, 2016 -- Diversicare Healthcare Services, Inc. (NASDAQ:DVCR) today announced that it is scheduled to report financial results for its third quarter ended September 30, 2016, on Thursday,...
Vascular Solutions Reports Third Quarter Results
Oct 24, 2016 20:05 pm UTC| Business
Q3 revenue increased 13% to $41.8 million, near the top end of guidanceQ3 GAAP EPS of $0.31, at the top end of guidanceGuidance for Q4 revenue set at $43.0-$44.0 million, representing growth of 14% at the midpointGuidance...
Oct 24, 2016 20:05 pm UTC| Business
-- CARE trial clinical data highlight the contribution of therapeutic drug management in guiding targeted dosing of plazomicin in critically ill patients with antibiotic resistant gram-negative infections -- --...
TESARO Announces Participation in Three Investor Conferences
Oct 24, 2016 20:05 pm UTC| Business
WALTHAM, Mass., Oct. 24, 2016 -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced its participation in three upcoming investor conferences. The three conferences are: The...